Medical treatment of tuberculosis-update 2011 [Medikamentöse therapie der tuberkulose-update 2011]

Simple item page
dc.contributor.authorvon Groote-Bidlingmaier F.
dc.contributor.authorDiacon A.H.
dc.date.accessioned2011-10-13T16:59:03Z
dc.date.available2011-10-13T16:59:03Z
dc.date.issued2011
dc.description.abstractTuberculosis is the second most common cause of death from an infectious disease after HIV/AIDS and the leading cause of death from an infectious disease in HIV-co-infected patients. Currently, drug susceptible TB is treated with a four drug regimen given over a period of two months followed by two drugs for four months. Drug resistant tuberculosis requires more complex and longer treatment with alternative substances. New antituberculosis drugs are currently being developed and investigated and are urgently needed to treat drug susceptible and drug resistant TB. © 2011 by Verlag Hans Huber, Hogrefe AG, Bern.
dc.description.versionReview
dc.identifier.citationTherapeutische Umschau
dc.identifier.citation68
dc.identifier.citation7
dc.identifier.citationhttp://www.scopus.com/inward/record.url?eid=2-s2.0-79960064818&partnerID=40&md5=50b07aa8c00c6a66064378b63278d07e
dc.identifier.issn405930
dc.identifier.other10.1024/0040-5930/a000183
dc.identifier.urihttp://hdl.handle.net/10019.1/16960
dc.subjecttuberculostatic agent
dc.subjectdrug sensitivity
dc.subjectreview
dc.subjecttuberculosis
dc.subjectAIDS-Related Opportunistic Infections
dc.subjectAntitubercular Agents
dc.subjectDrug Administration Schedule
dc.subjectDrug Interactions
dc.subjectDrug Therapy, Combination
dc.subjectExtensively Drug-Resistant Tuberculosis
dc.subjectHumans
dc.subjectInternationality
dc.subjectMicrobial Sensitivity Tests
dc.subjectTuberculosis, Multidrug-Resistant
dc.subjectTuberculosis, Pulmonary
dc.titleMedical treatment of tuberculosis-update 2011 [Medikamentöse therapie der tuberkulose-update 2011]
dc.typeReview
Files
Collections
Stellenbosch University - Scopus Publications